SPECIAL NOTICE
99 -- NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
- Notice Date
- 3/17/2015
- Notice Type
- Special Notice
- NAICS
- 921190
— Other General Government Support
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Rockville, Maryland, 20852, United States
- ZIP Code
- 20852
- Solicitation Number
- S15-100
- Archive Date
- 5/1/2015
- Point of Contact
- SBO Help Desk,
- E-Mail Address
-
NCIOASupport@centeva.com
(NCIOASupport@centeva.com)
- Small Business Set-Aside
- N/A
- Description
- National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of solicitation for offers. In accordance with FAR 15.201(d), this special notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to: 1) publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR); and 2) increase participation by qualified HUBZone small business, small, small disadvantaged, women-owned small business, veteran-owned small business and service-disabled veteran-owned small business concerns, as applicable. The FNLCR is a Government-Owned Contractor-Operated (GOCO) Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research Inc. for the National Cancer Institute (NCI) under Prime Contract No. HHSN261200800001E, which provides Operations and Technical Support (OTS) for the Frederick National Lab. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this notice as no information is being requested. Please be advised that any submissions provided despite the aforementioned notice that no information is requested become Government property and will not be returned, nor will there be any ensuing discussions or debriefings of any responses. Responses submitted to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any. The solicitation referenced below is issued by Leidos Biomedical Research, Inc. (Leidos Biomed), a wholly owned subsidiary of Leidos Corporation under its prime contract with the National Cancer Institute (NCI) at Frederick. Leidos Biomed is the Operations and Technical Support Contractor for the operation of the Frederick National Laboratory for Cancer Research (FNLCR) under contract from the National Cancer Institute (NCI). Leidos Biomed is responsible for managing the scientific and administrative aspects of the FNLCR's research endeavors. Title: DCR Ebola Studies: Data Collection and Analytic Services in Support of US Liberia Joint Research Partnership Project Background and Objectives: Assistance is needed for data collection, analytic services, and biometric technologies in support of the Ebola outbreak in Liberia. The goals of data collection and analytic services are to analyze social media sources to understand the sentiment around Ebola clinical research studies, and track any negative change in sentiment that may require immediate remedial action. The goal of biometric development and operations is to provide a mechanism for accurate tracking, identification, and follow up for subjects enrolled in Ebola clinical research studies in Liberia. The objective of this request is to provide resources needed to respond to an urgent health crisis. The subcontractor shall have proven capabilities in developing and operating data collection, analytic services, and a biometric program. The subcontractor will be expected to liaise with the Ebola Working Group team. Data from this research will be used to inform future treatment and prevention options and research design. The procurement of social analytics services and biometric technology is of paramount importance and is expected to lead to quicker and more efficient participant consent, enrollment and follow-up of subjects, and study outcomes for clinical research trials in Liberia. Proposal Submission Deadline:Noon (EST) on Thursday, April 17, 2015 Contact Details: For a copy of the Solicitation and Draft Leidos Agreement please contact: Charlee Franklin at charlee.franklin@fnlcr.nih.gov For information concerning other opportunities with the FNLCR, please refer to: http://ncioa.cancer.gov/oa-internet/sbo/welcome.jsp
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/RCB/S15-100/listing.html)
- Record
- SN03670205-W 20150319/150317235256-b83b31171f92d95ba5d0c0cdaf87cecc (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |